Time to omit interim CT imaging during frontline chemoimmunotherapy for patients with follicular lymphoma?

Ross Thomas Salvaris; Chan Yoon Cheah

doi:10.1080/10428194.2022.2142057

Time to omit interim CT imaging during frontline chemoimmunotherapy for patients with follicular lymphoma?

Internal Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Number of pages	3
Journal	LEUKEMIA & LYMPHOMA
DOIs	https://doi.org/10.1080/10428194.2022.2142057
Publication status	E-pub ahead of print - 3 Nov 2022

Access to Document

10.1080/10428194.2022.2142057

Cite this

@article{33d25d8cc82043e8ae30a2f19c6dc4c3,

title = "Time to omit interim CT imaging during frontline chemoimmunotherapy for patients with follicular lymphoma?",

keywords = "POSITRON-EMISSION-TOMOGRAPHY, PREDICTIVE-VALUE, PROGNOSTIC VALUE, F-18-FDG PET/CT, FDG-PET, THERAPY, TRIAL, HODGKIN, IMPACT, SCAN",

author = "Salvaris, {Ross Thomas} and Cheah, {Chan Yoon}",

year = "2022",

month = nov,

day = "3",

doi = "10.1080/10428194.2022.2142057",

language = "English",

journal = "Leukemia and Lymphoma",